Linked Life Data

18855724

Source:http://linkedlifedata.com/resource/pubmed/id/18855724

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
11
pubmed:dateCreated
2008-10-15
pubmed:abstractText
There has been considerable in vivo evidence that chemokine receptor CXCR4 and its endogenous ligand CXCL12 modulate some important physiological and pathophysiological processes, including cancer metastasis, angiogenesis, invasion, growth and progression. In this review we elucidate key aspects of CXCL12-CXCR4 signaling system with emphasis on peptide-based and small-molecule CXCR4 inhibitors.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
1389-5575
pubmed:author
pubmed:issnType
Print
pubmed:volume
8
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1075-87
pubmed:meshHeading
pubmed:year
2008
pubmed:articleTitle
CXCR4 receptor as a promising target for oncolytic drugs.
pubmed:affiliation
Small Molecule Drug Discovery, ChemDiv, Inc., San Diego, California 92121, USA.
pubmed:publicationType
Journal Article, Review